Dietary counseling: The ingredient for successfully addressing the use of herbal supplements and probiotics in chronic kidney disease

Advances in Chronic Kidney Disease

Volumn 21, Issue 4, 2014, Pages 377-384

  Kirk, Judy ^a   Dunker, Karen S ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

Chronic kidney disease; Complementary or alternative medicine; Counseling; Herbal supplements; Probiotics

Indexed keywords

ASTRAGALUS EXTRACT; ECHINACEA EXTRACT; GARCINIA CAMBOGIA EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; ISPAGULA; KAVA; PROBIOTIC AGENT; PLANT MEDICINAL PRODUCT;

CHRONIC KIDNEY DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG USE; ECHINACEA; FOOD AND DRUG ADMINISTRATION; GARCINIA CAMBOGIA; GINKGO BILOBA; GINSENG; HERBAL MEDICINE; HUMAN; NEPHROLOGIST; NUTRITIONAL COUNSELING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; HERB DRUG INTERACTION; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

DIETARY SUPPLEMENTS; HERB-DRUG INTERACTIONS; HUMANS; PLANT PREPARATIONS; PROBIOTICS; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84902956337     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.05.001     Document Type: Review

References (43)

1. Akyol A., Yildirim Y., Toker E., Yavuz B. The use of complementary and alternative medicine among chronic renal failure patients. J Clin Nurs 2011, 20(7-8):1035-1043.
2. Burrowes J., Van Houten G. Herbs and dietary supplement use in patients with stage 5 chronic kidney disease-issues in renal nutrition. Nephrol Nurs J 2006, 33(1):85-88.
3. Nahin R.L., Barnes P.M., Stussman B.J. Cost of Complementary and Alternative Medicine (CAM) and Frequency of Visits to CAM Practitioners: United States, 2007. National Health Statistics Reports; No. 18 2009, National Center for Health Statistics, Hyattsville, MD.
4. Barnes P.M., Bloom B., Nahin R.L. Complementary and Alternative Medicine Use among Adults and Children: United States, 2007. National Health Statistics Reports; No. 12 2008, National Center for Health Statistics, Hyattsville, MD.
5. Guidelines for the evaluation of probiotics in food. Joint FAO/WHO Working Group Meeting; 30 April-1 May; London, Ontario, Canada; 2002.
6. National Kidney Foundation. Use of herbal supplements in chronic kidney disease. Available at Accessed October 16,2013. http://www.kidney.org/atoz/content/herbalsupp.cfm.
7. National Institute of Health. Patent Center for Complementary and Alternative Medicine (NCCAM). Available at: Accessed October 16,2013. http://nccam.nih.gov.
8. Fu P.P., Chiang H.M., Xia Q., et al. Dietary supplements and herbal medicine initiative 2009, National Toxicology Program. National Institute of Health, Bethesda, MD.
9. Bakhshaee M., Jabbari F., Hoseini S., et al. Effect of silymarin in the treatment of allergic rhinitis. Otolaryngol Head Neck Surg 2011, 145(6):904-909.
10. Chandran B., Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Physiotother Res 2012, 26(11):1719-1725.
11. Belcaro G., Cesarone M.R., Dugall M., et al. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev 2010, 15(4):337-344.
12. Kuptniratsaikul V., Thanakhumtorn S., Chinswangwatanakul P., et al. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J Altern Complement Med 2009, 15(8):891-897.
13. Drozdov V.N., Kim V.A., Tkachenko E.V., Varvanina G.G. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip. J Altern Complement Med 2012, 18(6):583-588.
14. Terry R., Posadzki P., Watson L.K., Ernst E. The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med 2011, 12(12):1808-1818.
15. Bronstein A.C., Spyker D.A., Cantilena L.R., et al. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol (Phila) 2010, 48(10):979-1178.
16. Li X., Wang H. Chinese herbal medicine in the treatment of chronic kidney disease. Adv Chronic Kidney Dis 2005, 12(3):276-281.
17. Herbal Medicine: Expanded Commission E Monographs 2000, 221-225. Lippincott Williams & Wilkins, Newton, MA.
18. Matsunaga N., Imai S., Inokuchi Y., et al. Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage invitro and invivo. Mol Nutr Food Res 2009, 53(7):869-877.
19. Geller S.E., Shulman L.P., van Breemen R.B., et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009, 16(6):1156-1166.
20. Paul Grant P., Ramasamy S. An update on plant derived anti-androgens. Int J Endocrinol Metab 2012, 10(2):497-502.
21. Barry M.J., Meleth S., Lee J.Y., et al. Effect of increasing doses of saw palmetto on lower urinary tract symptoms: a randomized trial. JAMA 2011, 306(12):1344-1351.
22. Andriole G.L., McCullum-Hill C., Sandhu G.S., Crawford E.D., Barry M.J., Cantor A. The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial. J Urol 2013, 189(2):486-492. CAMUS Study Group.
23. Belcaro G., Dugall M., Luzzi R., Hosoi M., Corsi M. Improvements ofvenous tone with pycnogenol in chronic venous insufficiency: an exvivo study on venous segments. Int J Angiol 2014, 23(1):47-52.
24. Vinciguerra G., Belcaro G., Cesarone M.R., et al. Cramps and muscular pain: prevention with Pyconogenol in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy. Angiology 2006, 57(3):331-339.
25. Cesarone M.R., Belcaro G., Rohdewald P., et al. Improvement of diabetic microangiopathy with pycnogenol: a prospective, controlled study. Angiology 2006, 57(4):431-436.
26. Lee S.H., Ahn Y.M., Ahn S.Y., et al. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008, 14(6):715-721.
27. Dasgupta A., Tso G., Wells A. Effect of Asian ginseng, Siberian ginseng, and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by Digoxin III, a new digoxin immunoassay. J Clin Lab Anal 2008, 22(4):295-301.
28. Reeds D.N., Patterson B.W., Okunade A., et al. Ginseng and ginsenoside re do not improve beta-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care 2011, 34(5):1071-1076.
29. DeKosky S.T., Williamson J.D., Fitzpatrick A.L., et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008, 300(19):2253-2262. Ginkgo Evaluation of Memory (GEM) Study Investigators.
30. Conz P.A., La Greca G., Benedetti P., et al. Fucus vesiculosus: a nephrotoxic alga?. Nephrol Dial Transpl 1998, 13(2):526-527.
31. Agarwal S.C., Crook J.R., Pepper C.B. Herbal remedies-how safe are they? A case report of polymorphic ventricular tachycardia/ventricular fibrillation induced by herbal medication used for obesity. Int J Cardiol 2006, 106(2):260-261.
32. Jiang L., Deng L., Wu T. Chinese medicinal herbs for influenza. Cochrane Database Syst Rev 2013, (3):CD004559.
33. Eshghi F., Hosseinimehr S.J., Rahmani N., et al. Effects of Aloe vera cream on posthemorrhoidectomy pain and wound healing: results of a randomized, blind, placebo-control study. J Altern Complement Med 2010, 16(6):647-650.
34. Roth M., Timmermann B.N., Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos 2011, 39(5):920-926.
35. Stevinson C., Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med 2000, 1(2):91-99.
36. Rapaport M.H., Nierenberg A.A., Howland R., et al. The treatment of minor depression with St. John's wort or citalopram: failure to show benefit over placebo. J Psychiatr Res 2011, 45(7):931-941.
37. Blumenthal M., Goldberg A., Brinckman J. St John's Wort. Herbal Medicine: Expanded Commission E Monographs 2000, 359-366. Lippincott Williams & Wilkins, Newton, MA. M. Blumenthal, A. Goldberg, J. Brinckman (Eds.).
38. Oz M. Weight Loss. Available at: Accessed October 16,2013. http://www.doctoroz.com/topic/weight-loss.
39. Cerulli J., Grabe D.W., Gauthier I., et al. Chromium picolinate toxicity. Ann Pharmacother 1998, 32(4):428-431.
40. Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty; 2013. Available at: Accessed March 17,2014. http://naturaldatabase.therapeuticresearch.com/.
41. Rozenfeld V., Crain J.L., Callahan A.K. Possible augmentation of warfarin effect by glucosamine-chondroitin. Am J Health Syst Pharm 2004, 61(3):306-307.
42. Gray H.C., Hutcheson P.S., Slavin R.G. Is glucosamine safe in patients with seafood allergy (letter)?. J Allergy Clin Immunol 2004, 114(2):459-460.
43. Sherman P.M., Ossa J.C., Johnson-Henry K. Unraveling mechanisms of action of probiotics. Nutr Clin Pract 2009, 24(1):10-14.